RIOK2 and cancer: The results demonstrated that high expression of RIOK2 was associated with CD8+T cells, CD4+Th2 cells, CD4+Treg cells, and cancer-associated fibroblast infiltration in pan-cancer, whereas CD4+Th1 cells, macrophages, and natural killer cells showed the opposite association (Figure 7A).